Sandra Calvin Travere Therapeutics, Inc. (TVTX) insider trading activity
Sandra Calvin is SVP, CHIEF ACCOUNTING OFFICER of Travere Therapeutics, Inc.. Currently has a direct ownership of 54,927 shares of TVTX, which is worth approximately $943,645. The most recent transaction as insider was on Nov 25, 2024, when has been sold 12,090 shares (Common Stock) at a price of $18.3 per share, resulting in proceeds of $221,247. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
54.9K
5.59%
3M change
30.01%
12M change
Total Value Held
$943,645
Sandra Calvin Transaction History
SC
Sandra Calvin
SVP, CHIEF ACCOUNTING OFFICER
San Diego, CA